| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Bill of Rights for patients with cancer in Europe
|
Lawler, Mark
|
|
2014
|
15 |
3 |
p. 258-260
3 p.
|
artikel
|
| 2 |
Affordable cancer care: pipedream or achievable reality?
|
Collingridge, David
|
|
2014
|
15 |
3 |
p. 257-258
2 p.
|
artikel
|
| 3 |
August: Osage County
|
Cantor, Abi
|
|
2014
|
15 |
3 |
p. 264-265
2 p.
|
artikel
|
| 4 |
Basal-cell carcinoma: no response versus relapse
|
Bassukas, Ioannis D
|
|
2014
|
15 |
3 |
p. e104-e105
nvt p.
|
artikel
|
| 5 |
Basal-cell carcinoma: no response versus relapse – Author's reply
|
Williams, Hywel C
|
|
2014
|
15 |
3 |
p. e105-
1 p.
|
artikel
|
| 6 |
Beauty and the Breast
|
Burki, Talha Khan
|
|
2014
|
15 |
3 |
p. 266-
1 p.
|
artikel
|
| 7 |
Biomarkers in blood could help to detect pancreatic cancer
|
Tanday, Sanjay
|
|
2014
|
15 |
3 |
p. e108-
1 p.
|
artikel
|
| 8 |
Can whole-body MRI replace 18F-fluorodeoxyglucose PET/CT?
|
Kwee, Thomas C
|
|
2014
|
15 |
3 |
p. 243-244
2 p.
|
artikel
|
| 9 |
Cervical cancer: screening and risk with age
|
Burki, Talha Khan
|
|
2014
|
15 |
3 |
p. e107-
1 p.
|
artikel
|
| 10 |
Comparative genomic hybridisation array and DNA sequencing to direct treatment of metastatic breast cancer: a multicentre, prospective trial (SAFIR01/UNICANCER)
|
André, Fabrice
|
|
2014
|
15 |
3 |
p. 267-274
8 p.
|
artikel
|
| 11 |
Correction to Lancet Oncol 2013; 14: 1245
|
|
|
2014
|
15 |
3 |
p. e106-
1 p.
|
artikel
|
| 12 |
Correction to Lancet Oncol 2014; 15: 133
|
|
|
2014
|
15 |
3 |
p. e106-
1 p.
|
artikel
|
| 13 |
Correction to Lancet Oncol 2007; 8: 1099
|
|
|
2014
|
15 |
3 |
p. e106-
1 p.
|
artikel
|
| 14 |
Crystals and cancer: good vibrations or bad intentions?
|
Harding, Victoria
|
|
2014
|
15 |
3 |
p. 263-264
2 p.
|
artikel
|
| 15 |
Definitive chemoradiotherapy with FOLFOX versus fluorouracil and cisplatin in patients with oesophageal cancer (PRODIGE5/ACCORD17): final results of a randomised, phase 2/3 trial
|
Conroy, Thierry
|
|
2014
|
15 |
3 |
p. 305-314
10 p.
|
artikel
|
| 16 |
Delivering maximum clinical benefit at an affordable price: engaging stakeholders in cancer care
|
Kelly, Ronan J
|
|
2014
|
15 |
3 |
p. e112-e118
nvt p.
|
artikel
|
| 17 |
Does comparative effectiveness research promote rationing of cancer care?
|
Peppercorn, Jeffrey
|
|
2014
|
15 |
3 |
p. e132-e138
nvt p.
|
artikel
|
| 18 |
Dovitinib versus sorafenib for third-line targeted treatment of patients with metastatic renal cell carcinoma: an open-label, randomised phase 3 trial
|
Motzer, Robert J
|
|
2014
|
15 |
3 |
p. 286-296
11 p.
|
artikel
|
| 19 |
Evidence-informed frameworks for cost-effective cancer care and prevention in low, middle, and high-income countries
|
Chalkidou, Kalipso
|
|
2014
|
15 |
3 |
p. e119-e131
nvt p.
|
artikel
|
| 20 |
Fast-tracked approval of drugs and tests in Australia
|
Bagcchi, Sanjeet
|
|
2014
|
15 |
3 |
p. e110-
1 p.
|
artikel
|
| 21 |
Filling a gap in cervical cancer screening programmes
|
Wentzensen, Nicolas
|
|
2014
|
15 |
3 |
p. 249-251
3 p.
|
artikel
|
| 22 |
2014 Gastrointestinal Cancers Symposium
|
McLarnon, Andy
|
|
2014
|
15 |
3 |
p. 262-
1 p.
|
artikel
|
| 23 |
Gene sequencing yields new leukaemia target
|
Bagcchi, Sanjeet
|
|
2014
|
15 |
3 |
p. e110-
1 p.
|
artikel
|
| 24 |
Harm reduction and e-cigarettes: not evidence-based
|
Taleb, Ziyad Ben
|
|
2014
|
15 |
3 |
p. e104-
1 p.
|
artikel
|
| 25 |
HPV vaccinations do not encourage risky sexual behaviour
|
Tanday, Sanjay
|
|
2014
|
15 |
3 |
p. e109-
1 p.
|
artikel
|
| 26 |
Idelalisib: targeting PI3Kδ in B-cell malignancies
|
Gilbert, Judith A
|
|
2014
|
15 |
3 |
p. e108-
1 p.
|
artikel
|
| 27 |
Improving the therapeutic ratio in non-operable oesophageal cancer
|
Burmeister, Bryan
|
|
2014
|
15 |
3 |
p. 248-249
2 p.
|
artikel
|
| 28 |
Ionising radiation-free whole-body MRI versus 18F-fluorodeoxyglucose PET/CT scans for children and young adults with cancer: a prospective, non-randomised, single-centre study
|
Klenk, Christopher
|
|
2014
|
15 |
3 |
p. 275-285
11 p.
|
artikel
|
| 29 |
Lenalidomide and second malignancies in myeloma patients
|
Pratt, Guy
|
|
2014
|
15 |
3 |
p. 253-254
2 p.
|
artikel
|
| 30 |
Melanoma as a model for precision medicine in oncology
|
Kaufman, Howard L
|
|
2014
|
15 |
3 |
p. 251-253
3 p.
|
artikel
|
| 31 |
Microbiota and radiation-induced bowel toxicity: lessons from inflammatory bowel disease for the radiation oncologist
|
Ferreira, Miguel R
|
|
2014
|
15 |
3 |
p. e139-e147
nvt p.
|
artikel
|
| 32 |
Pancreatic cancer in the spotlight
|
The Lancet Oncology,
|
|
2014
|
15 |
3 |
p. 241-
1 p.
|
artikel
|
| 33 |
Pathological complete response is no surrogate for survival
|
Burki, Talha Khan
|
|
2014
|
15 |
3 |
p. e111-
1 p.
|
artikel
|
| 34 |
PFS as a surrogate for overall survival in metastatic melanoma
|
Kim, Kevin B
|
|
2014
|
15 |
3 |
p. 246-248
3 p.
|
artikel
|
| 35 |
Pharmacokinetics and safety of subcutaneous rituximab in follicular lymphoma (SABRINA): stage 1 analysis of a randomised phase 3 study
|
Davies, Andrew
|
|
2014
|
15 |
3 |
p. 343-352
10 p.
|
artikel
|
| 36 |
Plain packaging in Australia boosts calls to Quitline
|
Tanday, Sanjay
|
|
2014
|
15 |
3 |
p. e107-
1 p.
|
artikel
|
| 37 |
Safety and efficacy of vemurafenib in BRAF V600E and BRAF V600K mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label study
|
McArthur, Grant A
|
|
2014
|
15 |
3 |
p. 323-332
10 p.
|
artikel
|
| 38 |
SAFIR01: steps towards precision treatment in breast cancer
|
Swanton, Charles
|
|
2014
|
15 |
3 |
p. 242-243
2 p.
|
artikel
|
| 39 |
Second primary malignancies with lenalidomide therapy for newly diagnosed myeloma: a meta-analysis of individual patient data
|
Palumbo, Antonio
|
|
2014
|
15 |
3 |
p. 333-342
10 p.
|
artikel
|
| 40 |
Sentinel-node biopsy boosts melanoma treatment
|
Bagcchi, Sanjeet
|
|
2014
|
15 |
3 |
p. e111-
1 p.
|
artikel
|
| 41 |
Smoke-free Sochi showcases Russia's tobacco control effort
|
Burki, Talha Khan
|
|
2014
|
15 |
3 |
p. 261-
1 p.
|
artikel
|
| 42 |
Standard forward-viewing colonoscopy versus full-spectrum endoscopy: an international, multicentre, randomised, tandem colonoscopy trial
|
Gralnek, Ian M
|
|
2014
|
15 |
3 |
p. 353-360
8 p.
|
artikel
|
| 43 |
Subcutaneous rituximab: a practical approach?
|
Tobinai, Kensei
|
|
2014
|
15 |
3 |
p. 254-255
2 p.
|
artikel
|
| 44 |
Surrogate endpoints for overall survival in metastatic melanoma: a meta-analysis of randomised controlled trials
|
Flaherty, Keith T
|
|
2014
|
15 |
3 |
p. 297-304
8 p.
|
artikel
|
| 45 |
The LuLu Sessions
|
Towey, Francesca
|
|
2014
|
15 |
3 |
p. 265-266
2 p.
|
artikel
|
| 46 |
Third-line dovitinib in metastatic renal cell carcinoma
|
Schmidinger, Manuela
|
|
2014
|
15 |
3 |
p. 245-246
2 p.
|
artikel
|
| 47 |
Triage by methylation-marker testing versus cytology in women who test HPV-positive on self-collected cervicovaginal specimens (PROHTECT-3): a randomised controlled non-inferiority trial
|
Verhoef, Viola M J
|
|
2014
|
15 |
3 |
p. 315-322
8 p.
|
artikel
|
| 48 |
What is the effect of more sensitive diagnostic technology?
|
Ransohoff, David F
|
|
2014
|
15 |
3 |
p. 256-257
2 p.
|
artikel
|
| 49 |
WHO resolution on access to palliative care
|
Burki, Talha Khan
|
|
2014
|
15 |
3 |
p. e109-
1 p.
|
artikel
|
Tijdschrift beschrijving